Clinical TrialsSearch results
Number of results: 973
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A phase I trial of unrelated bone marrow transplantation for adult T cell leukemia/lymphoma following reduced intensity conditioning regimen.
- Adult T cell leukemia/lymphoma
- Grant for anticancer project from Ministry of Health, Welfare, and Labor of Japan.
- 2008-09-08
Other
- A multi institutional phase II trial of peripheral blood stem cell transplantation for adult T cell leukemia/lymphoma following reduced intensity conditioning regimen.
- Adult T cell leukemia/lymphoma
- Grant for anticancer project from Ministry of Health, Welfare, and Labor of Japan
- 2006-05-01
Other
- Phase III study of VCAP-AMP-VECP vs. biweekly CHOP in aggressive adult T-cell leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.
- adult T-cell leukemia / lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-17
Completed
- Single-dose study of OMD-001 in healthy adult volunteers
- Adult T-cell Leukemia-Lymphoma
- Murakami Harumi
- 2021-01-20
Completed
- Sequential combination therapy with CHOP and mogamulizumab in untreated primary ATLL patients
- adult T-cell leukemia-lymphoma
- Kato Koji
- 2019-03-18
Recruiting
- Single-center, open-label, single-arm study study to investigate efficacy and safety of Hydroxychloroquine in ATLL patients
- Adult T-Cell Leukemia-Lymphoma
- Amano Masahiro
- 2023-01-26
Recruiting
- Autologous Dendritic Cell Vaccine Therapy Targeting HTLV-1 Specific Antigen for Adult T-Cell Leukemia/Lymphoma
- Adult T-Cell Leukemia/Lymphoma
- Suehiro Youko
- 2021-04-20
Completed
- Uncommon EGFR mutations conducted with Osimertinib in patients with NSCLC: A phase 2 study
- Advanced / recurrent non-small cell lung cancer (NSCLC)
- Kubota Kaoru
- 2020-04-08
Completed
- A phase 2 study of osimertinib in elderly patients with non-small-cell lung cancer
- advanced / recurrent non-small cell lung cancer (NSCLC)
- Uchino Junji
- 2018-09-03
Recruiting
- TORG1938 (EPONA Study)
- Advanced / recurrent non-small cell lung cancer (NSCLC)
- Goto Yasushi
- 2020-09-01